Holland EC - Search Results

1

DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance.

Squatrito M, Holland EC. Squatrito M, et al. Among authors: holland ec. Cancer Res. 2011 Sep 15;71(18):5945-9. doi: 10.1158/0008-5472.CAN-11-1245. Epub 2011 Sep 13. Cancer Res. 2011. PMID: 21917735 Review.

2

Gliomagenesis: genetic alterations and mouse models.

Holland EC. Holland EC. Nat Rev Genet. 2001 Feb;2(2):120-9. doi: 10.1038/35052535. Nat Rev Genet. 2001. PMID: 11253051 Review.

3

Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.

Tanwar MK, Gilbert MR, Holland EC. Tanwar MK, et al. Among authors: holland ec. Cancer Res. 2002 Aug 1;62(15):4364-8. Cancer Res. 2002. PMID: 12154041

4

Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.

Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN, Holland EC. Uhrbom L, et al. Among authors: holland ec. Cancer Res. 2002 Oct 1;62(19):5551-8. Cancer Res. 2002. PMID: 12359767

5

Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.

Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC. Shih AH, et al. Among authors: holland ec. Cancer Res. 2004 Jul 15;64(14):4783-9. doi: 10.1158/0008-5472.CAN-03-3831. Cancer Res. 2004. PMID: 15256447

6

Mouse models of human cancer as tools in drug development.

Holland EC. Holland EC. Cancer Cell. 2004 Sep;6(3):197-8. doi: 10.1016/j.ccr.2004.09.004. Cancer Cell. 2004. PMID: 15380508 Free article.

7

Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.

Momota H, Nerio E, Holland EC. Momota H, et al. Among authors: holland ec. Cancer Res. 2005 Aug 15;65(16):7429-35. doi: 10.1158/0008-5472.CAN-05-1042. Cancer Res. 2005. PMID: 16103096

8

Platelet-derived growth factor (PDGF) and glial tumorigenesis.

Shih AH, Holland EC. Shih AH, et al. Among authors: holland ec. Cancer Lett. 2006 Feb 8;232(2):139-47. doi: 10.1016/j.canlet.2005.02.002. Epub 2005 Aug 31. Cancer Lett. 2006. PMID: 16139423 Review.

9

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

Lassman AB, Rossi MR, Raizer JJ, Abrey LE, Lieberman FS, Grefe CN, Lamborn K, Pao W, Shih AH, Kuhn JG, Wilson R, Nowak NJ, Cowell JK, DeAngelis LM, Wen P, Gilbert MR, Chang S, Yung WA, Prados M, Holland EC. Lassman AB, et al. Among authors: holland ec. Clin Cancer Res. 2005 Nov 1;11(21):7841-50. doi: 10.1158/1078-0432.CCR-05-0421. Clin Cancer Res. 2005. PMID: 16278407 Clinical Trial.

10

Genetically engineered models have advantages over xenografts for preclinical studies.

Becher OJ, Holland EC. Becher OJ, et al. Among authors: holland ec. Cancer Res. 2006 Apr 1;66(7):3355-8, discussion 3358-9. doi: 10.1158/0008-5472.CAN-05-3827. Cancer Res. 2006. PMID: 16585152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page